10.1155/2019/5080843 24 SunX.SunP.ZhenD.XuX.YangL.FuD.et al (2022)
While the peptide has been studied for decades and has shown promising results in animal research, there is currently insufficient clinical evidence to establish the peptide therapys safety and effectiveness in humans
This cjc 1295 ipamorelin blend pairs CJC-1295 (a growth hormone-releasing hormone analog) with Ipamorelin (a growth hormone secretagogue)
PubMed laboratory research record [PMID: 221519] PubMed record related to this compound for laboratory literature review
Health status considerations: Generally healthy adults with physician clearance, individuals without contraindications (pregnancy, active malignancy, severe organ disease), those willing to commit to proper administration protocols and monitoring, and patients who understand the research-purposes-only status and informed consent requirements
During the retention trial that occurred 24 h later, mice were placed in the illuminated chamber, and the latency to enter the dark chamber was recorded (i.e., step-through latency)